ClinicalTrials.gov
public full text
Public Domain
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
alzheimer-salzheimer-s-diseasebiomarkerdeliriumdementiamental-disordersneurodegenerative-diseasestau
Alzheimer's disease (AD) is the most common cause of dementia and currently has no disease modifying treatments or simple accurate diagnostic tests. The goal of this project is to study how tau (a protein thought to cause AD) is made, transported and cleared in the human body. Better understanding of these processes may lead to improved understanding of AD, earlier diagnosis and a way to evaluate treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease#1096358
- Imaging Tau Deposition in the Brain of Elderly Subjects#893276
- A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment#1120231
- A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer’s disease#398839
- Contribution of Tau pathology to mitochondrial impairment in neurodegeneration#948366
Record · ID 1030326
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive